does the us aripiprazole label list 10 to 15 mg/day for adult schizophrenia?
“The label lists 10 to 15 milligrams per day.”
a host said on Psychopharmacology and Psychiatry Updates, 2026-10-28, at 09:53. hear it in context → the speaker cited: the label.
the episode: First-Episode Psychosis in Women (at 09:53). we link the show's own page; we do not re-host audio.
first, the part that holds
the host is right: the US aripiprazole label lists 10 to 15 mg/day as the recommended dose for adults with schizophrenia, and the same 10 to 15 mg/day as the starting dose.
what we found when we went and looked
we read two current US aripiprazole labels on DailyMed and the FDA's label server: an oral tablet label revised february 2025 and an orally disintegrating tablet label revised february 2022. both dosing tables give adults with schizophrenia an initial dose of 10 to 15 mg/day, a recommended dose of 10 to 15 mg/day and a maximum of 30 mg/day. section 2.1 says the "recommended starting and target dose" is 10 or 15 mg/day once daily. it also says the drug was effective across 10 to 30 mg/day, but doses above 10 or 15 mg/day were not more effective than 10 or 15 mg/day.
assertion by assertion
| assertion | verdict | what the record says |
|---|---|---|
| the US aripiprazole label lists 10 to 15 mg/day as the recommended dose for adult schizophrenia | confirmed | the highlights dosage table in both labels we read lists schizophrenia, adults: recommended dose 10 to 15 mg/day. section 2.1 says the recommended starting and target dose is 10 or 15 mg/day once a day, with or without food. we read generic labels, which by law match the reference product's labeling. we did not open the originator's own label file. [1][2] |
| 10 to 15 mg/day is also the label's starting dose for adults, not only the target | confirmed | the same table lists the initial dose for adults as 10 to 15 mg/day. the label says dose increases should generally wait 2 weeks, the time needed to reach steady state. [1][2] |
| the label's full adult range runs higher than 10 to 15 mg/day, but higher doses did not beat 10 or 15 mg/day in trials | confirmed | section 2.1: effective in a dose range of 10 to 30 mg/day, but doses higher than 10 or 15 mg/day were not more effective than 10 or 15 mg/day. the table lists a maximum of 30 mg/day. this comparison comes from the short-term trials described in the label, not from data on individual patients. [1][2] |
| the 10 to 15 mg/day figure is for adults; adolescents have a different recommended dose | confirmed | for adolescents aged 13 to 17 with schizophrenia, the tablet label gives a 2 mg/day start, then 5 mg/day after 2 days, then a 10 mg/day target after 2 more days. maximum is 30 mg/day. [1] |
both directions
for the speaker: both labels say exactly what the host said. the highlights table lists the adult schizophrenia recommended dose as 10 to 15 mg/day, and section 2.1 calls 10 or 15 mg/day the recommended starting and target dose. the label also says doses above 10 or 15 mg/day were not more effective in the trials it summarizes, which backs reading 10 to 15 as the label's recommended dose rather than just a starting point.
against: nothing in the label contradicts the quote. the clause is accurate but leaves things out. the label also lists 10 to 30 mg/day as the range where efficacy was shown and sets a 30 mg/day maximum, so 10 to 15 is not the whole range the label allows. the body text says "10 or 15 mg/day", meaning two dose choices, while the table writes it as a range, "10 to 15 mg/day". the figure applies to oral tablets and orally disintegrating tablets for adults only. it does not apply to adolescents, other indications or the long-acting injections, which have their own dosing.
what this cannot say
we read two generic labels, which must match the reference product's labeling, but we did not open the originator's own label file on fda.gov. a newer revision could in principle differ. the label reports trial-level dose findings and cannot say what dose suits any one person. it also lists adjustments for drug interactions and for people who metabolize the drug slowly, which we did not check here. we checked only the quoted clause, not anything else the host said in the episode.
sources, each one fetched and read
- US National Library of Medicine, DailyMed. Aripiprazole tablets, prescribing information (Amneal Pharmaceuticals LLC), revised 2025-02-20. setid 06dda03f-8481-46d6-af02-4f51e1a3a065 What we read there: dosage table, schizophrenia adults: initial dose 10-15 mg/day, recommended dose 10-15 mg/day, maximum dose 30 mg/day. section 2.1: "The recommended starting and target dose for aripiprazole tablets is 10 mg/day or 15 mg/day administered on a once-a-day schedule without regard to meals"; effective in 10 mg/day to 30 mg/day; "doses higher than 10 mg/day or 15 mg/day were not more effective than 10 mg/day or 15 mg/day." adolescents: target dose 10 mg/day. Fetched 2026-10-29 (HTTP 200). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06dda03f-8481-46d6-af02-4f51e1a3a065
- US Food and Drug Administration, structured product label. Aripiprazole orally disintegrating tablets, USP (Bionpharma Inc.), revised 2022-02-02. spl 033c5fc1-a495-4417-ae3b-4ae01b3e4289 What we read there: highlights, schizophrenia adults: initial dose "10 to 15 mg/day", recommended dose "10 to 15 mg/day", maximum dose "30 mg/day". section 2.1: starting dose 10 or 15 mg/day once a day; effective in a dose range of 10 to 30 mg/day; doses higher than 10 or 15 mg/day were not more effective than 10 or 15 mg/day; dose increases generally not before 2 weeks. Fetched 2026-10-29 (HTTP 200). https://www.accessdata.fda.gov/spl/data/033c5fc1-a495-4417-ae3b-4ae01b3e4289/033c5fc1-a495-4417-ae3b-4ae01b3e4289.xml
speakers are described by role, not named. one sentence is quoted under fair use, with attribution and a link to the original at the timestamp; we do not re-host audio or video. nothing on this page is a reason to start, stop or change a medication. if you have the file behind anything marked unverifiable, the research board is where people can answer. adam